12A - The Michigan Daily - Thursday, March 14, 2002 Blue resumes Big Ten grind against Badgers and Gophers ,. . .. By Brian Schick Daily Sports Writer The Michigan women's tennis team enjoyed its spring break a week later than the rest of the student body - a break from tough competi- tion at least. The Wolverines (0-2 Big Ten, 4-5 overall) return to action this weekend at the Varsity Tennis Center against Big Ten foes Wisconsin and Min- nesota. Michigan had taken a break from compe- tition last weekend after its meet in Tampa, Fla. against Southern Florida on March 2. Michigan's 7-0 win against the Bulls in Tampa was the first outdoor meet of the season, and the team enjoyed the fun in the sun. While the weather in Ann Arbor wasn't horrible, Michigan coach Bisty Ritt described the gor- geous weather in Tampa simply as "79 degrees and very windy." The venue proved to be a test for the team, as Michigan has not played out- doors the entire season. It was also a break from the Big Ten, which hasn't treated the Wolverines too kindly this season. So far, Michigan lost to the top two fin- ishers from last year (Northwestern and Illi- nois). "It was nice to get a break from the Big Ten," Ritt said of her time in Florida. "It was helpful (for us) to hit a lot of balls outside and get used to the heat and the wind. The team played well at all positions." Ritt used the break to hold several tough prac- tices in preparation for Wisconsin (3-0, 8-3) on Saturday and Minnesota (0-3, 4-9) on Sunday. "It was a long trip," Ritt said of the team's first road trip. "I think we needed days to rest and recover, but especially regroup and refocus on with what we did well on the trip and what we need to work on" Ritt indicated that the break came along at just the right time, as she felt the Wolverines VARSITY TENNIS CENTER Who: Michigan (0-2 Big Ten, 4-5 overall) vs. Wisconsin (3-0, 8-3) and Minnesota (0-3, 4-9) When: 11 a.m. Saturday and Sunday Latest: A healthy and rested Michigan team has an excellent chance of earning its first Big Ten victory of the season against the struggling Golden Gophers. needed to readjust to Ann Arbor and get back into their typical daily schedule of classes and practice. She felt that both players and coaches were happy for the break and didn't think it hurt any momentum from the win against South Florida. The time off this week also gave the Wolver- ines an extended chance to examine the Bad- gers, one of just two teams that is still undefeated in the Big Ten (Northwestern being the other). One of Michigan's two victories in the Big Ten last year came against Wisconsin. Minnesota is at the other end of the spectrum in terms of success in the Big Ten. The Gophers are a team that has yet to win in the conference thus far, and they haven't had much success out- side the Big Ten either. Minnesota lost to DePaul 5-2 on Feb. 15, while Michigan trounced the Blue Demons 6-1 in January. Michigan golfers stymied by harsh winter a BRETT MOUNTAIN/Daily Sophomore defenseman Mike Komisarek Is one of the Wolverines' biggest hitters and was rewarded with a first-team All-CCHA selection. Powers cannedbyFa1ons By Gennaro Filice For The Daily DEFENSE Continued from Page 8A three minutes Friday night, to be exact. The three-game series format of the first round allowed them to recover from the loss, but this is a luxury they no longer have. Michigan's defense must continue to limit the number of shots goalie Josh Blackburn faces. But it also needs to focus on preventing any and all breakdowns from occurring. "When it comes to playoff time, defense wins or loses games for you," Burnes said. "They're usually one-goal games and it's all defense. You have to let your defense create offense, and go from there." SEE YOU LATER, BUDDY: Bowling Green Athletic Director Paul Krebs announced yes- terday that coach Buddy Powers, who just completed his eighth year at Bowling Green, will not return next season. He held an all- time record of 135-149-26 at Bowling Green. The Falcons were hoping to do a little more damage in the CCHA this season after last year's conference tournament run. Last year, the ninth-seeded Falcons swept second-seeded Miami and defeated Northern Michigan in the play-in game before falling to Michigan State in the semifinals, 2-1. But the Falcons (7-18-3 CCHA, 9-25-6 over- all) couldn't cut it, as they finished 11th in the CCHA and were swept by Michigan State in the first round of this year's tournament. The Michigan women's golf team's biggest foe isn't the opposition. It isn't the course either. The Wolverines' toughest opponent isn't even what many golfers refer to as their great- est enemy - themselves. The main adversary of Michigan golfers this spring was none other than the Michigan winter. Although the winter has been mild around the Midwest, it has still wreaked havoc on the Wolverines' practice schedule. . "We haven't been able to play a course in four months," Michigan coach Kathy Teichert said. The Wolverines finished their fall season with a perfect 4-0 campaign, but they have sputtered this spring, finishing fourth in their first two tournaments. "I can't expect the same results as they had in the fall because there is just no course around us to play on," Teichert said. Michigan looks forward to hitting the links, and hopefully improving its record, at the upcoming- Hatter Spring Fling in Daytona, Fla. The tournament, which takes place Saturday and Sunday, will be the Wolverines' second trip to Florida in three weeks (Michigan last played in Bradenton, Fla. in the Midwest Classic). At the Midwest Classic, "I think we had a good second go-around for the spring. Our short game was a lot better," Teichert said. "Our goal in the Hatter Spring Fling is obviously to win and have some high performers." Teichert will keep the same lineup this week- end that she has played all year: Junior Kim Benedict, senior Misia Lemanski, freshman Laura Olin, senior Cortney Reno and senior LeAnna Wicks. . Much of the team's early success this season is due to the steady play of Benedict. Not only does Benedict lead Michigan in scoring with a 74.94 average (which places her 79th in the Golfweek/Sagarin individual rankings), but she has also been the team's low scorer in four of six tournaments. "Kim leads by example, and she's a very DAYTONA, FLA. What: The Hatter Spring Fling When: 8:40 a.m. Saturday, 8 a.m. Sunday Latest: Freshman Laura Olin has been a solid performer for Michigan, finishing in the top 15 in four different tour- naments this year. hard worker," Teichert said. "She is also a very good ball-striker." Another solid performer for Michigan has been Olin. Just a freshman, Olin has been a pleasant surprise for the Wolverines. She has played in all six tournaments this season, and her consistency shows in her four top-15 finishes. In the final day of the Midwest Classic, Olin record- ed a brilliant final round 72, earning her a tie for fourth place - Michigan's best individal finish. "I knew that she would be a good player for us," Teichert said. "I though it would take a lit- tle more time for her to develop, but she has shown a lot of ambition towards her game. She wants to play, but not only play, she wants to be a top scorer for the team." £3EKF1N'F~l rv FRENCH Continued from Page 8A collegiate one. The French have more time to rest in between their meets than the Wolverines, and they don't have to worry about going to class like Michi- gan does. "They get a lot more long breaks in between competition where they can really focus on learning a new skill or something along that line," Golder said. In late October, the French took fourth at the 2001 Artistic Gymnas- tics Championships in Belgium behind a strong performance from Francois Ruffier, and the French Come to the Dell table in front of Ulrich's Bookstore on March 14 to pick up a free T-shirt. Get spotted with the T-Shirt on Friday, March 15 and get a chance to win a FREE Dell Inspiron Notehookl!I Undergrads + Graduate Students " Engage in provocative summer study with Stanford faculty * Live on campus - just minutes from West Coast beaches * Develop friendships with students from around the world " Earn full-year credit in foreign languages and physics * New 3-week Institutes in Creative Writing & International Security Courses offered in: Psychology, Philosophy, Economics, Computer Science, Biology, Engineering, History, Political Science, Music, Drama, Classics, Chemistry, Athletics, Art & Art History, Mathematics, and English for Foreign Students Stanford University Summer Session Building 590, Room 103 *"Stanford, CA 94305-3005 Ph: (650)>723-3109 - Fax: (650) 725-6080 * Email: summersession@stanford.edu summersession.stanford.edu T-shirts will be available on a first come first serve basis starting at 9 A.M. More detail will be available at the Dell table on March14. inspire Isystem will be shipped to the winner approximately four weeks after the event. should be especially focused tomor- row, with the European Champi- onships quickly approaching. For Michigan, there is something special about facing a team from across the ocean. Golder says he has seen some additional intensity from his team over practice the last few weeks. "It's probably on their minds out- side of the gym more than just a reg- ular dual meet against a team like Illinois or Penn State," Golder said. "Not to trivialize a meet like that, those are important too, but this just brings a special focus." CRUSADERS Continued from Page SA Associate head coach Angela Jack- son filled in for Sue Guevara while, the head coach attended to her ill mother. As the head coach for a day, Jackson got a taste of the frustration Guevara has felt all season. "We just couldn't get it going offensively," Jackson said. "We scored a bunch of points (at the Big Ten Tournament). I thought we played very well there and thought we could build on that. It just didn't happen for whatever reason." The reason was Valparaiso's swarming defense, which Crusaders' coach Keith Freeman compared to the Wisconsin men's basketball team under Dick Bennett that went to the Final Four in 2000. "The way we play defense, if you aren't used to it, it's different," Jack- son said. "It is the old Dick Bennett stuff. We are contesting every pass." Valparaiso's improved rebounding in the second half was also crucial in the victory. After being outrebounded by nine in the first half, the Crusaders had 21 boards in the second stanza, including one that set up Valparaiso's key four-point possession. The Crusaders jumped out to a 30- 18 edge, led by Nieuwveen's 18 points. As a team, Wlparaiso shot 59 percent from inside the 3-point arc. Smith was the only Michigan player to record double digits in the first half, tallying 12 points. The Wolverines trailed the entire game but closed the deficit to just one point four minutes into the sec- ond half after a 9-2 run coming out of the lockerroom. YESTERDAY'S GAME Valparaiso (62) FG FT REB MIN M-A M-A 0-T A F PTS Schober 36 6-11 0-3 0-4 1 2 13 Gray 39 4-14 0-1 1-8 4 1 9 Nieuwveen 30 9-9 8-8 1-7 1 3 26 Boone 39 5-11 3-4 8-12 6 3 14 Knoester 37 0-6 0-0 0-2 2 3 0 McIntosh 2 0-0 0-0 0-0 0 0 0 Strangler 8 0-1 0-0 0-0 0 0 0 Springer 3 0-1 0-0 0-0 0 0 0 Frede 6 0-1 0-0 0-1 0 1 0 Totals 200 24-54 11-1610-3514 13 62 FG%: .444. FT%: .688. 3-point FG: 3-16, .188 (Schober 1-2, Boone 1-3, Gray 1-5, Springer 0-1, . Knoester 0-5) Blocks: 3 (Knoester 2, Springer). Steals: 9 (Nieuwveen 4, Knoester 2, Gray, Schober, Springer). Turnovers: 14 (Boone 4, Schober 4, Gray, Knoester, McIntosh, Nieuwveen). Technical fouls: none. I r c.b Cont race tive In ect ion medroxyprogesterone acetate injectable suspension 3irtk con~trol yJou -thindk afEou-t ju~st '+1- a year DEPO-PROVERA* Contraceptive Injection (medroxyprogesterone acetate injectable suspension, USP) This product is intended to prevent pregnancy. It does not protect against HIV Infection (AIDS) and other sexually transmitted diseases. What Is DEPO-PROVERA contraceptive Injection? DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an intramuscular injection (a shot) in the buttock or upper arm once every 3 months (13 weeks). To continue your contraceptive protection, you must return for your next injection promptly at the end of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to (but not the same as) the natural hormone progesterone, which is produced by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by preventing your egg cells from ripening. If an egg is not released from the ovanes during your menstrual cycle, it cannot become fertilized by sperm and result in pregnancy. DEPO-PROVERA also causes changes in the lining of your uterus that make it less likely for pregnancy to occur. How effective is DEPO-PROVERA Contraceptive Injection? The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the recommended dosage schedule exactly (see "How often do I get my shot of DEPO-PROVERA Contraceptive Injection?"). To make sure you are not pregnant when you first get DEPO-PROVERA Contraceptive Injection, your first inection must be given ONLY during the first 5 days of a normal menstrual period; ONLY within the first 5 days after childbirth if not breast-feeding; and, if exclusively breast-feeding ONLY at the sixth week after childbirth. It is a long-term injectable contraceptive when administered at 3-month (13-week) intervals. DEPO-PROVERA Contraceptive Injection is over 99% effective, making it one of the most reliable methods of birth control available. This means that the average annual pregnancy rate is less than one for every 1 00 women who use DEPO-PROVERA. The effectiveness of most contraceptive methods depends in pat on how reliably each woman uses the method. The effectiveness of DEPO-PROVERA depends only on the patient returning every 3 months (13 weeks) for her next injection. Your health-care provider will help you compare DEPO-PROVERA with other contraceptive methods and give you the information you need in order to decide which contraceptive method is the right choice for you. The following table shows the percent of women who got pregnant while usin different kinds of contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected in women who use each method exactly as it should be used) and the typical rate of pregnancy (which includes women who became pregnant because they forgot to use their birth control or because they'did not follow the directions exactly). Percent of Women Experiencing an Accidental Pregnancy in the First Year of Continuous Use if you have had cancer of the breast "if you have had a stroke i f you have or have had blood clots (phlebitis) in your legs " if you have problems with your liver or liver disease " if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other ingredients). What other things should I consider before using DEPO-PROVERA contraceptive Injection? You will have a physical examination before your doctor prescribes DEPO-PROVERA. It is important to tell your health-care provider if you have any of the following: " a family history of breast cancer - an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples " kidney disease - irregular or scanty menstrual periods - high blood pressure Smigraine headaches " asthma " epilepsy (convulsions or seizures) - diabetes or a family history of diabetes " a history of depression * if you are taking any prescription or over-the-counter medications This product is intended to prevent pregnancy. It does not protect against transmission of HIV (AIDS) and other sexually transmitted diseases such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. What if I want to become pregnant after using DEPO-PROVERA Contraceptive Injection? Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last injection for its effect to wear off. Based on the results from a large study done in the United States, for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that about half of those who become pregnant will do so in about 10 months after their last injection; about two thirds of those who become pregnant will do so in about 12 months; about 83% of those who become pregnant will do so in about I5 months; and about 93% of those who become prenant will do so in about 18 months after their last injection. The length of time you use EPO-PROVERA has no effect on how long it takes ou to become pregnant after you stop using it What are the risks of using DEPO-PROVERA Contraceptive Injection? I irregular Menstrual Bleeding The side effect reported most frequently by women who use DEPO-PROVERA for contraception is a change in their normal menstrual cycle. During the first year of using DEPO-PROVERA, you might have one or more of the following changes: irregular or unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding at all. Unusually heavy or continuous bleeding, however; is not a usual effect of DEPO-PROVERA; and if this hap pens, you Should see your health-care provider right away. With continued use of DEPO-PROVE d bleeding usually decreases, and many women stop having periods completely In clinical studies of DEPO-PROVERA. 55% of the women studied reported no menstrual bleeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual bleeding after 2 years of use. The reason that your periods stop is because DEPO-PROVERA 6.Qther Risks Women who use hormone-based contraceptives may have an increased risk of blood clots or stroke. Also, ifa contraceptive method fails, there is a possibility that the fertilized egg will begin to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should tell your health-care provider if you have any of the problems listed in the next section, What symptoms may signal problems while using DEPO-PROVERA Contraceptive Injection? Call your health-care provider immediately if any of these problems occur following an injection of DEPO-PROVERA: " sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot in the lung) - sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or speech, weakness, or numbness in an arm or leg (indicating a possible stroke) - severe pain or swelling in the calf (indicating a possible clot in the leg) " unusually heavy vaginal bleeding - severe pain or tendernessin the lower abdominal area p4ersistent pain. pus. or bleeding at the injection site e t e possible side effects of DEPO-PROVERA Contraceptive Injection? l.Weight Gain You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds during the first year of use. You may continue to gain weight after the first year. Women in one large study who used DEPO-PROVERA for 2 years gained an average total of 8.1 pounds over those ? years, or approximately 4 pounds per year. Women who continued for 4 years gained an average total of 13.8 pounds over those 4 years, or approximately 3.5 pounds per year. Women who continued for 6 years gained an average total of I 6.5 pounds over those 6 years, or approximately 2.75 pounds per year 2. Other Side Effects In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some women reported the following effects. that may or may not have been related to their use of DEPO-PROVERA:.Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal. discharge or irritation, breast swelling and tendemess, bloating, swelling of the hands or feet, backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot flashes, and joint pain. Other-problems were reported by very few of the women in the clinical trials, but some of these could be serious. These include convulsions, jaundice, urinary tract infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility, deep vein thrombosis, pulmonary embolus, breast cancer or cervical cancer. If these or any other problems occur during your use of DEPO-PROVERA, discuss them with your health-care provider Should any precautions be followed during use of DEPO-PROVERA Contraceptive Injection? IMissed Periods During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your periods may stop completey. If you have been receiving your DEPO-PROVERA injections regularly every 3 months (13 weeks), then you are probably not pregnant. However if you think that you may be pregnant, see your health-care provider 21aboratory Test Interactions If ou are scheduled for any laboratory tests, tell your health-care provider that you are using Lowest Method Expected wypical DEPO-PROVERA 0.3 03 Implants (Norplant) 02* 0.2* temale sterilization 0.2 0.4 a